This NDC is on FDA's drug shortage list (posted Jan 1, 2012)
Product Information
FENTANYL 100 MCG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $1.7864 per ML under NDC 00409909422. Its NADAC has been published 576 times since Nov 28, 2013.
FDA first approved this application on Jan 12, 1985. Its Orange Book therapeutic-equivalence code is AP.
Strength
50 ug/mL
Manufacturer
Hospira Inc.NDC
00409909422
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
FENTANYL CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA019115FDA Approved
1/12/1985
TE Code
AP
On Market Since
9/27/2005
Pharmacological Classes
Price Statistics
The NADAC for FENTANYL 100 MCG/2 ML VIAL has been published 576 times since Nov 28, 2013, and over the history we have for it it has risen 249.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7864 per ML |
|---|---|
| All-time high | $1.7864 (Sep 30, 2026) |
| All-time low | $0.3568 (Nov 19, 2014) |
| 52-week high | $1.7864 |
| 52-week low | $1.0131 |
| Median price | $0.6264 |
| Average price | $0.6651 |
| Largest weekly change | +82.4% (Jun 20, 2018) |
| Weeks tracked | 576 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FENTANYL CITRATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FENTANYL CITRATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENTANYL 100 MCG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FENTANYL 100 MCG/2 ML VIAL, manufactured by Hospira Inc., is $1.7864 per ML (NDC 00409909422), effective Sep 30, 2026.
How has the price of FENTANYL 100 MCG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for FENTANYL 100 MCG/2 ML VIAL has risen 249.4%. It has been tracked across 576 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FENTANYL 100 MCG/2 ML VIAL?
Since Nov 28, 2013, the NADAC for FENTANYL 100 MCG/2 ML VIAL has ranged from a low of $0.3568 (Nov 19, 2014) to a high of $1.7864 (Sep 30, 2026), with a median of $0.6264 per ML.
Are there cheaper alternatives to FENTANYL 100 MCG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of FENTANYL 100 MCG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FENTANYL 100 MCG/2 ML VIAL?
FENTANYL 100 MCG/2 ML VIAL (NDC 00409909422) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is FENTANYL 100 MCG/2 ML VIAL in shortage?
Yes — NDC 00409909422 is currently listed in FDA's drug shortage database (posted Jan 1, 2012).